Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


22.07.2019

1 Am J Pathol
3 Ann Otol Rhinol Laryngol
1 Ann Thorac Surg
5 BMC Cancer
1 BMC Surg
1 Br J Cancer
1 Cancer
1 Clin Cancer Res
1 Clin Nucl Med
1 Gastrointest Endosc
2 Head Neck
1 Int J Pediatr Otorhinolaryngol
1 Int J Radiat Oncol Biol Phys
3 Laryngoscope
1 Radiother Oncol
2 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. KONISHI T, Shiozaki A, Kosuga T, Kudou M, et al
    LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.
    Am J Pathol. 2019 Jul 16. pii: S0002-9440(18)30880.
    PubMed     Text format     Abstract available


    Ann Otol Rhinol Laryngol

  2. GARRETT SL, Trott K, Sebastiano C, Wolf MJ, et al
    Sensitivity of Fine-Needle Aspiration and Imaging Modalities in the Diagnosis of Low-Grade Mucoepidermoid Carcinoma of the Parotid Gland.
    Ann Otol Rhinol Laryngol. 2019;128:755-759.
    PubMed     Text format     Abstract available

  3. HARMS A, Kansara S, Stach C, Richardson PA, et al
    Swallowing Function in Survivors of Oropharyngeal Cancer Is Associated With Advanced T Classification.
    Ann Otol Rhinol Laryngol. 2019;128:696-703.
    PubMed     Text format     Abstract available

  4. PEREZ PI, McIlwain W, Winters J, Dhesi M, et al
    A Supraglottic Mass in a Pediatric Patient: An Unusual Presentation of Lymphoma.
    Ann Otol Rhinol Laryngol. 2019;128:774-777.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  5. CHAPMAN BC, Weyant M, Hilton S, Hosokawa PW, et al
    Analysis of the National Cancer Database Esophageal Squamous Cell Carcinoma in the United States.
    Ann Thorac Surg. 2019 Jul 11. pii: S0003-4975(19)31006.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. HARLE A, Guillet J, Thomas J, Demange J, et al
    HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report.
    BMC Cancer. 2019;19:277.
    PubMed     Text format     Abstract available

  7. CHE J, Wang Y, Zhang X, Chen J, et al
    Comparative efficacy of six therapies for Hypopharyngeal and laryngeal neoplasms: a network meta-analysis.
    BMC Cancer. 2019;19:282.
    PubMed     Text format     Abstract available

  8. FORSLUND O, Sugiyama N, Wu C, Ravi N, et al
    A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin.
    BMC Cancer. 2019;19:265.
    PubMed     Text format     Abstract available

  9. TESHIMA M, Tokita K, Ryo E, Matsumoto F, et al
    Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    BMC Cancer. 2019;19:245.
    PubMed     Text format     Abstract available

  10. REZAEI M, Khamaneh AM, Zarghami N, Vosoughi A, et al
    Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
    BMC Cancer. 2019;19:690.
    PubMed     Text format     Abstract available


    BMC Surg

  11. PREDA C, Branisteanu D, Armasu I, Danila R, et al
    Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics.
    BMC Surg. 2019;19:94.
    PubMed     Text format     Abstract available


    Br J Cancer

  12. GRONHOJ C, Jensen DH, Dehlendorff C, Marklund L, et al
    Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).
    Br J Cancer. 2018 May 24. pii: 10.1038/s41416-018-0107.
    PubMed     Text format     Abstract available


    Cancer

  13. SASAKI CT, Doukas SG, Costa J, Vageli DP, et al
    Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.
    Cancer. 2019 Jul 16. doi: 10.1002/cncr.32369.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  14. DUVVURI U, George J, Kim S, Alvarado D, et al
    Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2019 Jul 15. pii: 1078-0432.CCR-18-3453.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  15. LIU Y, Bai X, Mu D, Wang J, et al
    Focally Increased Iodine Activity in a Small Thymic Cyst.
    Clin Nucl Med. 2019;44:477-479.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  16. CAI SL, Li B, Tan WM, Niu XJ, et al
    Using deep learning system in endoscopy for screening of early esophageal squamous cell carcinoma (with video).
    Gastrointest Endosc. 2019 Jul 11. pii: S0016-5107(19)32051.
    PubMed     Text format     Abstract available


    Head Neck

  17. LU T, Xie X, Guo Q, Zhan S, et al
    Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25865.
    PubMed     Text format     Abstract available

  18. PAULI N, Mejersjo C, Fagerberg-Mohlin B, Finizia C, et al
    Temporomandibular disorder in head and neck cancer patients undergoing radiotherapy: Clinical findings and patient-reported symptoms.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25878.
    PubMed     Text format     Abstract available


    Int J Pediatr Otorhinolaryngol

  19. ROTH L, Moerdler S, Weiser D, Douglas L, et al
    Otolaryngologist and pediatric oncologist perspectives on the role of fine needle aspiration in diagnosing pediatric head and neck masses.
    Int J Pediatr Otorhinolaryngol. 2019;121:34-40.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  20. SUN XS, Liu SL, Luo MJ, Li XY, et al
    The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.
    Int J Radiat Oncol Biol Phys. 2019 Jul 15. pii: S0360-3016(19)33456.
    PubMed     Text format     Abstract available


    Laryngoscope

  21. VLANTIS AC, Wong EWY, Ng SK, Chan JYK, et al
    Narrow Band Imaging Endoscopy of the Nasopharynx for Malignancy: An Inter- and Intraobserver Study.
    Laryngoscope. 2019;129:1374-1379.
    PubMed     Text format     Abstract available

  22. FARHOOD Z, Simpson M, Ward GM, Walker RJ, et al
    Does anatomic subsite influence oral cavity cancer mortality? A SEER database analysis.
    Laryngoscope. 2019;129:1400-1406.
    PubMed     Text format     Abstract available

  23. HAN AY, Dhanjani S, Pettijohn K, Patel PB, et al
    Optimal resection margin for head and neck cutaneous melanoma.
    Laryngoscope. 2019;129:1386-1394.
    PubMed     Text format     Abstract available


    Radiother Oncol

  24. YU S, Zhang W, Ni W, Xiao Z, et al
    A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
    Radiother Oncol. 2019;140:159-166.
    PubMed     Text format     Abstract available


    Thyroid

  25. WANG JR, Zafereo M, Dadu R, Ferrarotto R, et al
    Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma.
    Thyroid. 2019 Jul 18. doi: 10.1089/thy.2019.0133.
    PubMed     Text format     Abstract available

  26. ITO Y, Ishikawa H, Kihara M, Hirokawa M, et al
    Control of lung metastases and colon polyposis with lenvatinib therapy in a patient with cribriform-morular variant of papillary thyroid carcinoma and an APC gene mutation: a case study.
    Thyroid. 2019 Jul 18. doi: 10.1089/thy.2019.0121.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: